<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.jnutbio.com//inpress?rss=yes"><title>The Journal of Nutritional Biochemistry - Articles in Press</title><description>The Journal of Nutritional Biochemistry RSS feed: Articles in Press. Devoted to advancements in nutritional sciences, the  The Journal of Nutritional Biochemistry  presents experimental nutrition 
research as it relates to: biochemistry, neurochemistry, molecular biology, toxicology, physiology and pharmacology. Rigorous reviews 
by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted 
in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research communications, 
the  The Journal of Nutritional Biochemistry  also periodically publishes emerging issues, conference summaries, experimental 
methods, symposium reports, metabolic pathways, and short communications.</description><link>http://www.jnutbio.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> Crown Copyright © 2010. Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:issn>0955-2863</prism:issn><prism:publicationDate>2010-07-26</prism:publicationDate><prism:copyright> Crown Copyright © 2010. Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000756/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000768/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528631000077X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000793/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000823/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000835/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000847/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000860/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000884/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000872/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000781/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000811/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000859/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528631000080X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000604/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000653/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000665/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000689/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000501/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000628/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000677/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000483/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000598/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000616/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528631000063X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000641/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000495/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000513/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000379/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000380/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000306/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000343/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000744/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000094/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000355/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000318/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000331/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528631000029X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528631000032X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000100/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000124/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000082/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000112/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000136/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000367/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002514/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000021/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000033/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000045/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286310000070/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000756/abstract?rss=yes"><title>Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000756/abstract?rss=yes</link><description>Abstract: Monocytes expressing toll-like receptor 4 (TLR4) play a major role in regulating the innate immune response and are involved in systemic inflammation. Previous studies have shown that Ginkgo biloba extract (GBE) may act as a therapeutic agent for some cardiovascular and neurological disorders. The objective of this study was to determine whether GBE could modulate immunity in human cells. The monocytic cell line THP-1 was used. Enzyme-linked immunosorbent assay results showed that lipopolysaccharide (LPS) induces the expression of monocyte chemotactic protein-1 (MIP-1), tumor necrosis factor-α, stromal cell-derived factor-1, and MIP-1α, and this induction may be repressed by GBE treatment due to TLR4 blockade. The Griess reagent assay and western blot analysis showed that GBE-mediated inhibition of TLR4 expression was associated with the activation of mitogen-activated protein kinase and production of nitric oxide (NO). Actinomycin D chase experiments demonstrated that GBE decreased the TLR4 mRNA stability in cells. Confocal microscopy and real-time polymerase chain reaction showed that GBE induced the expression of intracellular tristetraprolin (TTP). Transfection with TTP siRNA reversed the effects of GBE in naïve or TLR4-overexpressing cells. Treatment with SNAP (an NO donor) may increase intracellular TTP expression in cells. Immunoprecipitation analysis showed that GBE mediates TTP activation and increases the interaction of TTP with the 3′ untranslated region (UTR) of TLR4 mRNA by regulating NO production. Our findings indicate that GBE could decrease the sensitivity of monocytes to LPS. Utilizing TTP to control TLR4 expression may be a promising approach for controlling systemic inflammation, and GBE may have potential applications in the clinical treatment of immune diseases.</description><dc:title>Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression - Corrected Proof</dc:title><dc:creator>Yuan-Wen Lee, Jui-An Lin, Chuen-Chau Chang, Yung-Hsiang Chen, Po-Len Liu, Ai-Wei Lee, Jui-Chi Tsai, Chi-Yuan Li, Chien-Sung Tsai, Ta-Liang Chen, Feng-Yen Lin</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000768/abstract?rss=yes"><title>Cox-2 expression, PGE2 and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000768/abstract?rss=yes</link><description>Abstract: There is great interest in the role of polyunsaturated fatty acids (PUFAs) in promoting (n-6 class) or inhibiting (n-3 class) inflammation. Mammalian cells are devoid of desaturase that converts n-6 to n-3 PUFAs. Consequently, essential n-3 fatty acids must be supplied with the diet. We have studied the effect of endogenously produced n-3 PUFAs on colitis development in fat-1 transgenic mice carrying the Caenorhabditis elegans fat-1 gene encoding n-3 desaturase. Colonic cell lipid profile was measured by capillary gas chromatography in fat-1 and wild-type (WT) littermates fed standard diet supplemented with 10% (w/w) safflower oil rich (76%) in n-6 polyunsaturated linoleic acid (LA). Experimental colitis was induced by administrating 3% dextran sodium sulphate (DSS). Colitis was scored by histopatological analysis. Cyclooxygenase-2 (Cox-2) expression was evaluated by real time polymerase chain reaction. Prostaglandin E2 (PGE2) levels and cytokine production were determined by enzyme and microsphere-based immunoassays, respectively. The n-6/n-3 PUFA ratios in colonic cells of fat-1 mice were markedly lower (9.83±2.62) compared to WT (54.5±9.24, P&lt;.001). Results also showed an attenuation of colonic acute and chronic inflammation in fat-1 mice with significant decreases in PGE2 production (P&lt;.01) and Cox-2 expression (P&lt;.01). High levels of colitis-induced proinflammatory cytokines, interleukin (IL)-18, IL-1α, IL-1β, IL-6, monocytes chemotactic proteins 1, 2 and 3 (MCP 1,2,3), matrix metalloproteinase 9 and tumor necrosis factor α (TNF-α) were down-regulated in DSS acutely and chronically treated fat-1 mice. The expression of fat-1 gene in the colon was associated with endogenous n-3 PUFAs production, decreased Cox-2 expression, increased PGE2 and cytokine production.</description><dc:title>Cox-2 expression, PGE2 and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice - Corrected Proof</dc:title><dc:creator>Claudia Gravaghi, Krista M.D. La Perle, Paul Ogrodwski, Jing X. Kang, Fred Quimby, Martin Lipkin, Sergio A. Lamprecht</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528631000077X/abstract?rss=yes"><title>High-fat diets rich in medium- versus long-chain fatty acids induce distinct patterns of tissue specific insulin resistance - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528631000077X/abstract?rss=yes</link><description>Abstract: Excess dietary long-chain fatty acid (LCFA) intake results in ectopic lipid accumulation and insulin resistance. Since medium-chain fatty acids (MCFA) are preferentially oxidized over LCFA, we hypothesized that diets rich in MCFA result in a lower ectopic lipid accumulation and insulin resistance compared to diets rich in LCFA. Feeding mice high-fat (HF) (45% kcal fat) diets for 8 weeks rich in triacylglycerols composed of MCFA (HFMCT) or LCFA (HFLCT) revealed a lower body weight gain in the HFMCT-fed mice. Indirect calorimetry revealed higher fat oxidation on HFMCT compared to HFLCT (0.011.0±0.0007 vs. 0.0096±0.0015 kcal/g body weight per hour, P&lt;.05). In line with this, neutral lipid immunohistochemistry revealed significantly lower lipid storage in skeletal muscle (0.05±0.08 vs. 0.30±0.23 area%, P &lt;.05) and in liver (0.9±0.4 vs. 6.4±0.8 area%, P&lt;.05) after HFMCT vs. HFLCT, while ectopic fat storage in low fat (LF) was very low. Hyperinsulinemic euglycemic clamps revealed that the HFMCT and HFLCT resulted in severe whole body insulin resistance (glucose infusion rate: 53.1±6.8, 50.8±15.3 vs. 124.6±25.4 μmol min−1 kg−1, P&lt;.001 in HFMCT, HFLCT and LF-fed mice, respectively). However, under hyperinsulinemic conditions, HFMCT revealed a lower endogenous glucose output (22.6±8.0 vs. 34.7±8.5 μmol min−1 kg−1, P&lt;.05) and a lower peripheral glucose disappearance (75.7±7.8 vs. 93.4±12.4 μmol min−1 kg−1, P&lt;.03) compared to HFLCT-fed mice. In conclusion, both HF diets induced whole body insulin resistance compared to LF. However, the HFMCT gained less weight, had less ectopic lipid accumulation, while peripheral insulin resistance was more pronounced compared to HFLCT. This suggests that HF-diets rich in medium- versus long-chain triacylglycerols induce insulin resistance via distinct mechanisms.</description><dc:title>High-fat diets rich in medium- versus long-chain fatty acids induce distinct patterns of tissue specific insulin resistance - Corrected Proof</dc:title><dc:creator>Johan De Vogel-van den Bosch, Sjoerd A.A. van den Berg, Silvia Bijland, Peter J. Voshol, Louis M. Havekes, Hans A. Romijn, Joris Hoeks, Denis van Beurden, Matthijs K.C. Hesselink, Patrick Schrauwen, Ko Willems van Dijk</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000793/abstract?rss=yes"><title>Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000793/abstract?rss=yes</link><description>Abstract: Chronic low-grade inflammation in obesity is characterized by macrophage accumulation in white adipose tissue (WAT) and abnormal cytokine production. We tested the hypothesis that grape-seed procyanidin extract (PE), with known anti-inflammatory and antioxidant effects, would improve local and systemic inflammation in diet-induced obesity rats. First, we analyzed the preventive effects of procyanidins (30 mg/kg per day) on rats fed a 60% kcal fat diet for 19 weeks. Second, we induced cafeteria diet obesity for 13 weeks to investigate the corrective effects of two PE doses (25 and 50 mg/kg per day) for 10 and 30 days.In the preventive model, PE group had reduced not only body weight but also plasmatic systemic markers of inflammation tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP). The PE preventive treatment significantly showed an increased adiponectin expression and decreased TNF-α, interleukin-6 and CRP expression in mesenteric WAT and muscle TNF-α. A reduced NF-κB activity in liver is also observed which can be related to low expression rates of hepatic inflammatory markers found in PE group. Finally, PE dietary supplementation is linked to a reduced expression of Emr1 (specific marker of macrophage F4/80), which suggests a reduced macrophage infiltration of WAT.In the corrective model, however, only the high dose of PE reduced CRP plasma levels in the short treatment without changes in plasmatic TNF-α.In conclusion, orally ingested PE helps preventing imbalanced obesity cytokine pattern, but its corrective effects need to be further investigated. The dietary regular intake of food or drinks containing procyanidins might help prevent low-grade inflammatory-related diseases.</description><dc:title>Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats - Corrected Proof</dc:title><dc:creator>Ximena Terra, Víctor Pallarés, Anna Ardèvol, Cinta Bladé, Juan Fernández-Larrea, Gerard Pujadas, Josepa Salvadó, Lluís Arola, Mayte Blay</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000823/abstract?rss=yes"><title>Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000823/abstract?rss=yes</link><description>Abstract: Excess hepatic lipid accumulation and oxidative stress contribute to nonalcoholic fatty liver disease (NAFLD). Thus, we hypothesized that the hypolipidemic and antioxidant activities of green tea extract (GTE) would attenuate events leading to NAFLD. Obese mice (ob/ob; 5 weeks old, n=38) and their lean littermates (n=12) were fed 0%, 0.5% or 1% GTE for 6 weeks. Then, hepatic steatosis, oxidative stress and inflammatory markers were measured. Obese mice, compared to lean controls, had greater hepatic lipids and serum alanine aminotransferase (ALT). GTE at 1% lowered (P&lt;.05) hepatic lipids and ALT in obese mice. The GTE-mediated attenuation in hepatic steatosis was accompanied by decreased mRNA expression of adipose sterol regulatory element-binding protein-1c, fatty acid synthase, stearoyl CoA desaturase-1, and hormone-sensitive lipase and decreased serum nonesterified fatty acid concentrations. Immunohistochemical data indicated that steatotic livers from obese mice had extensive accumulation of tumor necrosis factor-α (TNF-α), whereas GTE at 1% decreased hepatic TNF-α protein and inhibited adipose TNF-α mRNA expression. Hepatic total glutathione, malondialdehyde and Mn- and Cu/Zn-superoxide dismutase activities in obese mice fed GTE were normalized to the levels of lean littermates. Also, GTE increased hepatic catalase and glutathione peroxidase activities, and these activities were inversely correlated with ALT and liver lipids. Collectively, GTE mitigated NAFLD and hepatic injury in ob/ob mice by decreasing the release of fatty acids from adipose and inhibiting hepatic lipid peroxidation as well as restoring antioxidant defenses and decreasing inflammatory responses. These findings suggest that GTE may be used as an effective dietary strategy to mitigate obesity-triggered NAFLD.</description><dc:title>Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice - Corrected Proof</dc:title><dc:creator>Hea Jin Park, Dana A. DiNatale, Min-Yu Chung, Young-Ki Park, Ji-Young Lee, Sung I. Koo, Meeghan O'Connor, Jose E. Manautou, Richard S. Bruno</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000835/abstract?rss=yes"><title>Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000835/abstract?rss=yes</link><description>Abstract: Nutritional therapy is a challenging but necessary dimension in the management of diabetes and neurodegenerative changes associated with it. The study evaluates the effect of vitamin D3 in preventing the altered function of cholinergic, insulin receptors and GLUT3 in the cerebral cortex of diabetic rats. Muscarinic M3 acetylcholine receptors in pancreas control insulin secretion. Vitamin D3 treatment in M3 receptor regulation in the pancreatic islets was also studied. Radioreceptor binding assays and gene expression was done in the cerebral cortex of male Wistar rats. Immunocytochemistry of muscarinic M3 receptor was studied in the pancreatic islets using specific antibodies. Y-maze was used to evaluate the exploratory and spatial memory. Diabetes induced a decrease in muscarinic M1, insulin and vitamin D receptor expression and an increase in muscarinic M3, α7 nicotinic acetylcholine receptor, acetylcholine esterase and GLUT3 expression. Vitamin D3 and insulin treatment reversed diabetes-induced alterations to near control. Diabetic rats showed a decreased Y-maze performance while vitamin D3 supplementation improved the behavioural deficit. In conclusion, vitamin D3 shows a potential therapeutic effect in normalizing diabetes-induced alterations in cholinergic, insulin and vitamin D receptor and maintains a normal glucose transport and utilisation in the cortex. In addition vitamin D3 modulated muscarinic M3 receptors activity in pancreas and plays a pivotal role in controlling insulin secretion. Hence our findings proved, vitamin D3 supplementation as a potential nutritional therapy in ameliorating diabetes mediated cortical dysfunctions and suggest an interaction between vitamin D3 and muscarinic M3 receptors in regulating insulin secretion from pancreas.</description><dc:title>Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats - Corrected Proof</dc:title><dc:creator>Peeyush T. Kumar, Sherin Antony, Mohan S. Nandhu, Jayanarayanan Sadanandan, George Naijil, Chiramadathikudiyil S. Paulose</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000847/abstract?rss=yes"><title>Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000847/abstract?rss=yes</link><description>Abstract: Oxidative cellular stress initiates Nrf2 translocation into the nucleus, thus inducing antioxidant response element (ARE)-mediated expression of Phase II enzymes involved in detoxification and antioxidant defence. We investigated whether coffee extracts (CEs) of different proveniences and selected constituents have an impact on the Nrf2/ARE pathway in human colon carcinoma cells (HT29). Assessed as increased nuclear Nrf2 protein, Nrf2 nuclear translocation was modulated by different CEs as observed by Western blot analysis. In addition to the known Nrf2 activator 5-O-caffeoylquinic acid (CGA), pyridinium derivatives like the N-methylpyridinium ion (NMP) were identified as potent activators of Nrf2 nuclear translocation and ARE-dependent gene expression of selected antioxidative Phase II enzymes in HT29. Thereby, the substitution pattern at the pyridinium core structure determined the impact on Nrf2-signalling. In contrast, trigonelline was found to interfere with Nrf2 activation, effectively suppressing the NMP-mediated induction of Nrf2/ARE-dependent gene expression. In conclusion, several coffee constituents, partly already present in the raw material as well as those generated during the roasting process, contribute to the Nrf2-translocating properties of consumer-relevant coffee. A fine tuning in the degradation/formation of activating and deactivating constituents of the Nrf2/ARE pathway during the roasting process appears to be critical for the chemopreventive properties of the final coffee product.</description><dc:title>Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression - Corrected Proof</dc:title><dc:creator>Ute Boettler, Katharina Sommerfeld, Nadine Volz, Gudrun Pahlke, Nicole Teller, Veronika Somoza, Roman Lang, Thomas Hofmann, Doris Marko</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000860/abstract?rss=yes"><title>High lactation index is associated with insulin sensitivity - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000860/abstract?rss=yes</link><description>Abstract: The aim of the study was to evaluate the contribution of lactation to insulin sensitivity in women 12 to 18 month postpartum using an oral glucose tolerance test (OGTT). Mean lactation index (LI), a scoring system that considers the establishment and maintenance of the lactation was used. Lactation index was calculated according to the number of months of breast-feeding per child with a maximum of 72 points. The mean LI was calculated by dividing the total number of points by the number of children. A cutoff point of 72 was considered for the LI. We investigated the inverse of the homeostasis model assessment (HOMASens) and the Cederholm index. Healthy women went through standardized interview and anthropometry. After a 10- to 12-h overnight fast, a 2-h OGTT was performed. Multiple regression analysis was performed with HOMASens and Cederholm index, which were adjusted for parity, percentage body fat, LI and presence/absence of breast-feeding. Both HOMASens and Cederholm index were negatively associated with percentage body fat (P&lt;.01), and Cederholm index was positively associated with LI (P=.01). Mean 120-min insulin levels were significantly lower in women with LI=72 when compared with LI&lt;72 women. Insulin sensitivity measured by the Cederholm index is positively associated with prolonged and sustained lactation, while percentage body fat presented a negative association. In this way, sustained lactation-associated metabolic changes are considered protective to women's health.</description><dc:title>High lactation index is associated with insulin sensitivity - Corrected Proof</dc:title><dc:creator>Teresa H.M. Da Costa, Leslie J. Bluck</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.013</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000884/abstract?rss=yes"><title>Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000884/abstract?rss=yes</link><description>Abstract: The inverse relationship between fat in bone marrow and bone mass in the skeleton of aging subjects is well known. However, there is no precise therapy for the treatment of bone marrow adiposity. We investigated the ability of conjugated linoleic acid (CLA) and fish oil (FO), alone or in combination, to modulate bone loss using 12 months old C57Bl/6J mice fed 10% corn oil diet as control or supplemented with 0.5% CLA or 5% FO or 0.5% CLA+5% FO for 6 months. We found, CLA-fed mice exhibited reduced body weight, body fat mass (BFM) and enhanced hind leg lean mass (HLLM) and bone mineral density (BMD) in different regions measured by dual energy x-ray absorptiometry (DXA); however, associated with fatty liver and increased insulin resistance; whereas, FO fed mice exhibited enhanced BMD, improved insulin sensitivity, with no changes in BFM and HLLM. Interestingly, CLA+FO fed mice exhibited reduced body weight, BFM, peroxisome proliferator-activated receptor gamma and cathepsin K expression in bone marrow with enhanced BMD and HLLM. Moreover, CLA+FO supplementation reduced liver hypertrophy and improved insulin sensitivity with remarkable attenuation of bone marrow adiposity, inflammation and oxidative stress in aging mice. Therefore, CLA with FO combination might be a novel dietary supplement to reduce fat mass and improve BMD.</description><dc:title>Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice - Corrected Proof</dc:title><dc:creator>Ganesh V. Halade, Md M. Rahman, Paul J. Williams, Gabriel Fernandes</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.015</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000872/abstract?rss=yes"><title>Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000872/abstract?rss=yes</link><description>Abstract: Diabetes is a proinflammatory state. We have previously shown increased monocyte proinflammatory cytokines in patients with Type 1 and Type 2 diabetes. High glucose induces proinflammatory cytokines via epigenetic changes. Curcumin, a polyphenol responsible for the yellow color of the spice turmeric, is known to exert potent anti-inflammatory activity in vitro. Recent studies indicate that it may regulate chromatin remodeling by inhibiting histone acetylation. In this study, we aimed to test the effect of curcumin on histone acetylation and proinflammatory cytokine secretion under high-glucose conditions in human monocytes. Human monocytic (THP-1) cells were cultured in presence of mannitol (osmolar control, mannitol) or normoglycemic (NG, 5.5 mmol/L glucose) or hyperglycemic (HG, 25 mmol/L glucose) conditions in absence or presence of curcumin (1.5–12.5 μM) for 72 h. Cytokine level, nuclear factor κB (NF-κB) transactivation, histone deacetylases (HDACs) activity, histone acetylases (HATs) activity were measured by western blots, quantitative reverse transcriptase-polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence staining. HG significantly induced histone acetylation, NF-κB activity and proinflammatory cytokine (interleukin 6, tumor necrosis factor α and MCP-1) release from THP-1 cells. Curcumin suppressed NF-κB binding and cytokine release in THP-1 cells. Also, since p300 histone acetyltransferase is a coactivator of NF-κB, we examined its acetylation. Curcumin treatment also significantly reduced HAT activity, level of p300 and acetylated CBP/p300 gene expression, and induced HDAC2 expression by curcumin. These results indicate that curcumin decreases HG-induced cytokine production in monocytes via epigenetic changes involving NF-κB. In conclusion, curcumin supplementation by reducing vascular inflammation may prevent diabetic complications.</description><dc:title>Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin - Corrected Proof</dc:title><dc:creator>Jung-Mi Yun, Ishwarlal Jialal, Sridevi Devaraj</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.014</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-23</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-23</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000781/abstract?rss=yes"><title>ATGL and HSL are not coordinately regulated in response to fuel partitioning in fasted rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000781/abstract?rss=yes</link><description>Abstract: Prolonged fasting is characterized by lipid mobilization (Phase 2), followed by protein breakdown (Phase 3). Knowing that body lipids are not exhausted in Phase 3, we investigated whether changes in the metabolic status of prolonged fasted rats are associated with differences in the expression of epididymal adipose tissue proteins involved in lipid mobilization. The final body mass, body lipid content, locomotor activity and metabolite and hormone plasma levels differed between groups. Compared with fed rats, adiposity and epididymal fat mass decreased in Phase 2 (approximately two- to threefold) and Phase 3 (∼4.5–14-fold). Plasma nonesterified fatty acids (NEFA) concentrations were increased in Phase 2 (approximately twofold) and decreased in Phase 3 (approximately twofold). Daily locomotor activity was markedly increased in Phase 3 (∼11-fold). Compared with the fed state, expressions of adipose triglyceride lipase (ATGL; mRNA and protein), hormone-sensitive lipase (HSL; mRNA) and phosphorylated HSL at residue Ser660 (HSL Ser660) were increased during Phase 2 (∼1.5–2-fold). HSL (mRNA and protein) and HSL Ser660 levels were lowered during Phase 3 (∼3–12-fold). Unlike HSL and HSL Ser660, ATGL expression did not correlate with circulating NEFA, mostly due to data from animals in Phase 3. At this stage, ATGL could play an essential role for maintaining a low mobilization rate of NEFA, possibly to sustain muscle performance and hence increased locomotor activity. We conclude that ATGL and HSL are not coordinately regulated in response to changes in fuel partitioning during prolonged food deprivation, ATGL appearing as the major lipase in late fasting.</description><dc:title>ATGL and HSL are not coordinately regulated in response to fuel partitioning in fasted rats - Corrected Proof</dc:title><dc:creator>Fabrice Bertile, Thierry Raclot</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-12</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-12</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000811/abstract?rss=yes"><title>Protocatechuic acid induces antioxidant/detoxifying enzyme expression through JNK-mediated Nrf2 activation in murine macrophages - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000811/abstract?rss=yes</link><description>Abstract: Protocatechuic acid (PCA) is a main metabolite of anthocyanins, whose daily intake is much higher than that of other polyphenols. PCA has biological effects, e.g., it induces the antioxidant/detoxifying enzyme gene expression. This study was aimed at defining the molecular mechanism responsible for PCA-induced over-expression of glutathione (GSH) peroxidase (GPx) and GSH reductase (GR) in J774 A.1 macrophages. New evidence is provided that PCA increases GPx and GR expression by inducing C-JUN NH2-terminal kinase (JNK)-mediated phosphorylation of Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2). RNA and proteins were extracted from cells treated with PCA (25 μM) for different time points. Quantitative real-time polymerase chain reaction and immunoblotting analyses showed a rapid increase in mRNA (&gt;60%) and protein (&gt;50%) for both the enzymes. This was preceded by the up-regulation of Nrf2, in terms of mRNA and protein, and by its significant activation as assessed by increased Nrf2 phosphorylation and nuclear translocation (+60%). By using specific kinase inhibitors and detecting the activated form, we showed that JNK was the main upstream kinase responsible for Nrf2 activation. Convincing evidence is provided of a causal link between PCA-induced Nrf2 activation and increased enzyme expression. By silencing Nrf2 and using a JNK inhibitor, enzyme enhancement was counteracted. Finally, with the ChIP assay, we demonstrated that PCA-activated Nrf2 specifically bound ARE sequences in enzyme gene promoters. Our study demonstrates for the first time that PCA improves the macrophage endogenous antioxidant potential by a mechanism in which JNK-mediated Nrf2 activation plays an essential role. This knowledge could contribute to novel diet-based approaches aimed at counteracting oxidative injury by reinforcing endogenous defences.</description><dc:title>Protocatechuic acid induces antioxidant/detoxifying enzyme expression through JNK-mediated Nrf2 activation in murine macrophages - Corrected Proof</dc:title><dc:creator>Rosaria Varì, Massimo D'Archivio, Carmelina Filesi, Simona Carotenuto, Beatrice Scazzocchio, Carmela Santangelo, Claudio Giovannini, Roberta Masella</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-12</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-12</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000859/abstract?rss=yes"><title>Dietary l-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000859/abstract?rss=yes</link><description>Abstract: Obesity is a major health crisis worldwide and new treatments are needed to fight this epidemic. Using the swine model, we recently reported that dietary l-arginine (Arg) supplementation promotes muscle gain and reduces body-fat accretion. The present study tested the hypothesis that Arg regulates expression of key genes involved in lipid metabolism in skeletal muscle and white adipose tissue. Sixteen 110-day-old barrows were fed for 60 days a corn- and soybean-meal-based diet supplemented with 1.0% Arg or 2.05% l-alanine (isonitrogenous control). Blood samples, longissimus dorsi muscle and overlying subcutaneous adipose tissue were obtained from 170-day-old pigs for biochemical studies. Serum concentrations of leptin, alanine and glutamine were lower, but those for Arg and proline were higher in Arg-supplemented pigs than in control pigs. The percentage of oleic acid was higher but that of stearic acid and linoleic acid was lower in muscle of Arg-supplemented pigs, compared with control pigs. Dietary Arg supplementation increased mRNA levels for fatty acid synthase in muscle, while decreasing those for lipoprotein lipase, glucose transporter-4, and acetyl-coenzyme A carboxylase-α in adipose tissue. Additionally, mRNA levels for hormone sensitive lipase were higher in adipose tissue of Arg-supplemented pigs compared with control pigs. These results indicate that Arg differentially regulates expression of fat-metabolic genes in skeletal muscle and white adipose tissue, therefore favoring lipogenesis in muscle but lipolysis in adipose tissue. Our novel findings provide a biochemical basis for explaining the beneficial effect of Arg in improving the metabolic profile in mammals (including obese humans).</description><dc:title>Dietary l-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle - Corrected Proof</dc:title><dc:creator>Bie Tan, Yulong Yin, Zhiqiang Liu, Wenjie Tang, Haijun Xu, Xiangfeng Kong, Xinguo Li, Kang Yao, Wanting Gu, Stephen B. Smith, Guoyao Wu</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.012</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-12</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-12</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528631000080X/abstract?rss=yes"><title>Effects of weight loss on erythrocyte membrane composition and fluidity in overweight and moderately obese women - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528631000080X/abstract?rss=yes</link><description>Abstract: A previous study showed chemical and physical impairment of the erythrocyte membrane of overweight and moderately obese women. The present study investigated the effects of a low-calorie diet (800 kcal/day deficit for 8 weeks) on erythrocyte membrane properties in 70 overweight and moderately obese (body mass index, 25–33 kg/m2) normotensive, nondiabetic women. At the end of dietary intervention, 24.3% of women dropped out, 45.7% lost less than 5% of their initial weight (Group I) and only 30% of patients lost at least 5% of their initial body weight (Group II). Group I showed no significant changes in erythrocyte membrane composition and function. The erythrocyte membranes of Group II showed significant reductions in malondialdehyde, lipofuscin, cholesterol, sphingomyelin, palmitic acid and nervonic acid and an increase in di-homo-γ-linolenic acid, arachidonic acid and membrane fluidity. Moreover, Group II showed an improvement in total cholesterol, low-density lipoprotein cholesterol, glycemia and insulin resistance. These changes in erythrocyte membrane composition could reflect a virtuous cycle resulting from the reduction in insulin resistance associated with increased membrane fluidity that, in turn, results in a sequence of metabolic events that concur to further improve membrane fluidity.</description><dc:title>Effects of weight loss on erythrocyte membrane composition and fluidity in overweight and moderately obese women - Corrected Proof</dc:title><dc:creator>Roberta Cazzola, Mariangela Rondanelli, Rosita Trotti, Benvenuto Cestaro</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-07-09</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-07-09</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000604/abstract?rss=yes"><title>A functional promoter polymorphism −607G&gt;C of WNT10B is associated with abdominal fat in Korean female subjects - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000604/abstract?rss=yes</link><description>Abstract: WNT10B has been implicated as a potential regulator of adipogenesis in cellular and animal models of obesity. In this study, we attempted to characterize the associations between common genetic polymorphisms of WNT10B and fat accumulation in a sample of 1029 Korean female subjects. Direct sequencing of genomic DNAs of 45 subjects identified six common single-nucleotide polymorphisms (SNPs) of WNT10B, which were in almost complete linkage disequilibrium. Among the six SNPs, −607G&gt;C (rs833840) showed differential nuclear factor binding in an electrophoretic mobility shift assay and differential promoter activity in a reporter assay, implicating it as a functional regulatory SNP. When body compositions of the subjects determined using bio-impedance analysis were compared according to their −607G&gt;C genotype, only body fat mass showed a significant association. Body masses of protein, mineral and water showed no association. For more accurate evaluation of the effects of −607G&gt;C genotype on body fat, cross-sectional fat areas of the subjects measured by abdominal computed tomography were compared. Genotype of −607G&gt;C was significantly associated with abdominal total fat and abdominal subcutaneous fat areas (P=.009 and P=.007 in recessive model, respectively). Of the 1029 subjects, 576 were treated with a 1 month very low calorie diet and changes of body weight and composition were compared with −607G&gt;C genotype. No significant associations were evident. This study is the first report of the association of common genetic polymorphism of WNT10B with human fat accumulation.</description><dc:title>A functional promoter polymorphism −607G&gt;C of WNT10B is associated with abdominal fat in Korean female subjects - Corrected Proof</dc:title><dc:creator>Il Chul Kim, Min Ho Cha, Dong Min Kim, Haeyong Lee, Jin Seok Moon, Sun Mi Choi, Kil Soo Kim, Yoosik Yoon</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-25</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-25</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000653/abstract?rss=yes"><title>Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000653/abstract?rss=yes</link><description>Abstract: Adipocyte-specific fatty acid-binding protein (A-FABP) is a cytoplasmic protein that is expressed in adipocytes and is closely associated with insulin resistance, metabolic syndrome, and Type 2 diabetes. We investigated the relationship between A-FABP as a surrogate marker of metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in apparently healthy subjects. We assessed clinical and biochemical metabolic parameters and measured serum levels of A-FABP, high-sensitivity C-reactive protein and tumor necrosis factor-α (TNF-α) in 494 subjects who were divided into two groups according to the presence of NAFLD by abdominal ultrasonography. All parameters associated with metabolic syndrome were significantly higher in patients with NAFLD (P&lt;.001). A-FABP showed positive correlation with TNF-α, homeostasis model assessment index of insulin resistance (HOMA-IR), and metabolic syndrome (P&lt;.001) when adjusted for age and sex. The odds ratio for the risk of NAFLD in the highest tertile of A-FABP compared with the lowest tertile was 7.36 (CI 3.80–14.27, P&lt;.001) after adjustment for age and sex; 4.52 (CI 2.22–9.20, P&lt;.001) after adjustment for age, sex, HOMA-IR and metabolic syndrome and 2.86 (CI 1.11–7.35, P&lt;.05) after further adjustment for all metabolic parameters including TNF-α. The serum level of A-FABP was independently associated with NAFLD and showed significant correlation with TNF-α, HOMA-IR, and metabolic syndrome.</description><dc:title>Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects - Corrected Proof</dc:title><dc:creator>Young-Choon Kim, Yong-Kyun Cho, Won-Young Lee, Hong-Joo Kim, Jung-Ho Park, Dong-Il Park, Chong-Il Sohn, Woo-Kyu Jeon, Byung-Ik Kim, Se-Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Sun-Woo Kim, Seung-Ho Ryu</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-25</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-25</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000665/abstract?rss=yes"><title>Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155 - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000665/abstract?rss=yes</link><description>Abstract: In the present study the effect of quercetin and its major metabolites quercetin-3-glucuronide (Q3G) and isorhamnetin on inflammatory gene expression was determined in murine RAW264.7 macrophages stimulated with lipopolysaccharide. Quercetin and isorhamnetin but not Q3G significantly decreased mRNA and protein levels of tumor necrosis factor alpha. Furthermore a significant decrease in mRNA levels of interleukin 1β, interleukin 6, macrophage inflammatory protein 1α and inducible nitric oxide synthase was evident in response to the quercetin treatment. However Q3G did not affect inflammatory gene expression. Anti-inflammatory properties of quercetin and isorhamnetin were accompanied by an increase in heme oxygenase 1 protein levels, a downstream target of the transcription factor Nrf2, known to antagonize chronic inflammation. Furthermore, proinflammatory microRNA-155 was down-regulated by quercetin and isorhamnetin but not by Q3G. Finally, anti-inflammatory properties of quercetin were confirmed in vivo in mice fed quercetin-enriched diets (0.1 mg quercetin/g diet) over 6 weeks.</description><dc:title>Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155 - Corrected Proof</dc:title><dc:creator>Christine Boesch-Saadatmandi, Agnieszka Loboda, Anika E. Wagner, Anna Stachurska, Alicja Jozkowicz, Jozef Dulak, Frank Döring, Siegfried Wolffram, Gerald Rimbach</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-25</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-25</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000689/abstract?rss=yes"><title>Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000689/abstract?rss=yes</link><description>Abstract: Dietary soy isoflavones including genistein and daidzein have been shown to have favorable effects during estrogen deficiency in experimental animals and humans. We have evaluated osteogenic effect of cladrin and formononetin, two structurally related methoxydaidzeins found in soy food and other natural sources. Cladrin, at as low as 10 nM, maximally stimulated both osteoblast proliferation and differentiation by activating MEK-Erk pathway. On the other hand, formononetin maximally stimulated osteoblast differentiation at 100 nM that involved p38 MAPK pathway but had no effect on osteoblast proliferation. Unlike daidzein, these two compounds neither activated estrogen receptor in osteoblast nor had any effect on osteoclast differentiation. Daily oral administration of each of these compounds at 10.0 mg kg−1 day−1 dose to recently weaned female Sprague–Dawley rats for 30 consecutive days, increased bone mineral density at various anatomic positions studied. By dynamic histomorphometry of bone, we observed that rats treated with cladrin exhibited increased mineral apposition and bone formation rates compared with control, while formononetin had no effect. Cladrin had much better plasma bioavailability compared with formononetin. None of these compounds exhibited estrogen agonistic effect in uteri. Our data suggest that cladrin is more potent among the two in promoting parameters of peak bone mass achievement, which could be attributed to its stimulatory effect on osteoblast proliferation and better bioavailability. To the best of our knowledge, this is the first attempt to elucidate structure–activity relationship between the methoxylated forms of daidzein and their osteogenic effects.</description><dc:title>Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats - Corrected Proof</dc:title><dc:creator>Abnish K. Gautam, Biju Bhargavan, Abdul M. Tyagi, Kamini Srivastava, Dinesh K. Yadav, Manmeet Kumar, Akanksha Singh, Jay S. Mishra, Amar Bahadur Singh, Sabyasachi Sanyal, Rakesh Maurya, Lakshmi Manickavasagam, Sheelendra P. Singh, Wahajuddin Wahajuddin, Girish K. Jain, Naibedya Chattopadhyay, Divya Singh</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-25</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-25</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000501/abstract?rss=yes"><title>Dietary isoflavone increases insulin-like growth factor-I production, thereby promoting hair growth in mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000501/abstract?rss=yes</link><description>Abstract: Sensory neurons release calcitonin gene-related peptide (CGRP) upon activation. We previously demonstrated that CGRP increases insulin-like growth factor-I (IGF-I) production in various tissues of mice including the skin. We demonstrated that isoflavone increases the CGRP synthesis in the dorsal root ganglion (DRG) neurons in rats. Since IGF-I plays a critical role in hair growth, we hypothesized that isoflavones may promote hair growth by increasing the IGF-I production in hair follicles. We examined this hypothesis using wild-type (WT) and CGRP-knockout (CGRP−/−) mice. Isoflavone significantly increased the CGRP mRNA levels in DRG neurons isolated from WT mice (P&lt;.01). Administration of isoflavone for 3 weeks increased the dermal levels of CGRP, IGF-I and IGF-I mRNA in WT mice, but not in CGRP−/− mice. Isoflavone administration increased the immunohistochemical expression of IGF-I in hair follicle dermal papilla cells in WT mice. Significant enhancements of hair follicle morphogenesis, hair regrowth, and hair pigmentation were also observed in WT mice administered isoflavone. However, none of these effects in WT mice were observed in CGRP−/− mice.These observations strongly suggest that isoflavone might increase IGF-I production in the hair follicle dermal papilla cells in mice through increasing CGRP production in the sensory neurons, thereby promoting hair growth associated with melanogenesis in mice.</description><dc:title>Dietary isoflavone increases insulin-like growth factor-I production, thereby promoting hair growth in mice - Corrected Proof</dc:title><dc:creator>Juan Zhao, Naoaki Harada, Hiroki Kurihara, Naomi Nakagata, Kenji Okajima</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-24</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-24</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000628/abstract?rss=yes"><title>Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFκB pathway in human B cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000628/abstract?rss=yes</link><description>Abstract: Nutrition can modify the onset or severity of diseases and recent changes in eating habits are supposed to promote immunoglobulin (Ig) E-dependent disorders. The n-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) possesses immunomodulatory properties and has been shown to influence chronic and allergic inflammatory disorders in vivo. Here, we examined the impact of DHA on primary human B cells to elucidate its potential role in direct regulation of IgE production and the underlying mechanisms of action. Therefore, cells were stimulated with anti-CD40/interleukin (IL)-4 in the presence of DHA. Subsequently, Ig production, generation of antibody secreting cells, epsilon-germline transcript (ɛGLT) and activation induced desaminase (AID) expression as well as IgE relevant signaling pathways were analyzed. Our results reveal that DHA inhibits IgE production (75±14%) and, depending on concentration, the differentiation of IgE secreting cells (59±27%). The reduction of IgE is accompanied by a direct inhibition of the switching process indicated by decreased ɛGLT and AID transcription. DHA causes both a reduced CD40 dependent nuclear factor κB-p50 translocation into the nucleus and a decreased IL-4 receptor expression which was associated with a reduction of IL-4 driven signal transducer and activator of transcription 6 phosphorylation. Taken together, DHA inhibits IgE production of human B cells by direct interference with both the CD40 and the IL-4 signaling pathway. The data provide one explanation for the anti-allergic role of DHA at the molecular level.</description><dc:title>Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFκB pathway in human B cells - Corrected Proof</dc:title><dc:creator>Christin Weise, Kerstin Hilt, Milena Milovanovic, Dennis Ernst, Ralph Rühl, Margitta Worm</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-24</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-24</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000677/abstract?rss=yes"><title>Serum palmitic acid–oleic acid ratio and the risk of coronary artery disease: a case-control study - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000677/abstract?rss=yes</link><description>Abstract: Serum free fatty acids are risk factors for future coronary artery disease (CAD). We investigated the association between serum palmitic acid (PA)–oleic acid (OA) ratio and CAD risk in a case-control (n=108/129) study. The PA–OA ratio was associated with future CAD events independently of standard lipid values. The PA–OA ratio was significantly associated with the risk of fatal CAD [odds ratio (OR): 60.4; 95% confidence interval (CI): 11.5–316.9; P&lt;.001] while inversely associated in nonfatal CAD group (OR: 0.11; 95% CI: 0.02–0.53; P&lt;.01), and no distinct modification by sex was found. Receiver-operating characteristic (ROC) analysis found that PA–OA ratio did as well as triglyceride (TG) and apolipoprotein B (apo B)–high-density lipoprotein cholesterol (HDLC) ratio at discriminating fatal CAD (area under ROC, TG, 0.692; apo B–HDLC, 0.683; PA–OA, 0.768, P&lt;.001), and had similar effect with HDLC at discriminating nonfatal CADs (area under ROC, HDLC, 0.649; PA–OA, 0.659, P&lt;.01).These findings suggested that PA–OA ratio did as well as and even better than traditional risk factors and arteriography examination in discriminating fatal and nonfatal CAD events. Serum PA–OA ratio could be a new factor for CAD risk assessment and prediction.</description><dc:title>Serum palmitic acid–oleic acid ratio and the risk of coronary artery disease: a case-control study - Corrected Proof</dc:title><dc:creator>Ling-bing Sun, Yan Zhang, Qiang Wang, Hao Zhang, Wei Xu, Jie Zhang, Jie Xiang, Qing-guo Li, Yang Xiang, Dong-jin Wang, Chen-yu Zhang</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-24</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-24</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000483/abstract?rss=yes"><title>Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000483/abstract?rss=yes</link><description>Abstract: This study was conducted to test the hypothesis that n-3 polyunsaturated fatty acids are able to down-regulate expression of adhesion molecules and nuclear factor-κB (NF-κB) activation in vascular endothelial cells, in addition to reducing atherosclerotic lesions in vivo. We report here that docosahexaenoic acid (DHA) reduces atherosclerotic lesions in the aortic arteries of apolipoprotein E knockout (apoE–/–) mice. Consistent with the observation in animal study, DHA inhibited THP-1 cell adhesion to tumor necrosis factor α (TNF-α)-activated human aortic endothelial cells (HAECs). Expression of vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) on the cell surface of HAECs was determined by cell-surface enzyme-linked immunosorbent assay. DHA and eicosapentaenoic acid decreased VCAM-1 expression in a dose-dependent manner in TNF-α treated HAECs, while cis-linoleic acid and arachidonic acid did not have any significant effect on either VCAM-1 or ICAM-1 expression. Moreover, DHA significantly reduced VCAM-1 protein expression in the cell lysates of TNF-α-treated HAECs, as determined by Western blot analysis. In line with NF-κB signaling pathway, DHA suppressed the TNF-α-activated IκBα phosphorylation and degradation as well as IκB kinase-β phosphorylation. Subsequently, translocation of the NF-κB (p50/p65) and AP-1 (c-Fos/c-Jun) subunits was down-regulated by DHA in the nucleus of HAECs. These results suggest that DHA negatively regulates TNF-α-induced VCAM-1 expression through attenuation of NF-κB signaling pathway and AP-1 activation. This study provides evidence that DHA may contribute to the prevention of atherosclerosis and inflammatory diseases in vivo.</description><dc:title>Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells - Corrected Proof</dc:title><dc:creator>Tzu-Ming Wang, Chun-Jung Chen, Tzong-Shyuan Lee, Han-Yi Chao, Wen-Huey Wu, Shu-Chen Hsieh, Huey-Herng Sheu, An-Na Chiang</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-23</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-23</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000598/abstract?rss=yes"><title>DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000598/abstract?rss=yes</link><description>Abstract: Late-onset Alzheimer's disease seems to be a multi-factorial disease with both genetic and non-genetic, environmental, possible causes. Recently, epigenomics is achieving a major role in Alzheimer's research due to its involvement in different molecular pathways leading to neurodegeneration. Among the different epigenetic modifications, DNA methylation is one of the most relevant to the disease. We previously demonstrated that presenilin1 (PSEN1), a gene involved in amyloidogenesis, is modulated by DNA methylation in neuroblastoma cells and Alzheimer's mice in an experimental model of nutritionally altered one-carbon metabolism. This alteration, obtained by nutritional deficiency of B vitamins (folate, B12 and B6) hampered S-adenosylmethionine (SAM)-dependent methylation reactions. The aim of the present paper was to investigate the regulation of DNA methylation machinery in response to hypomethylating (B vitamin deficiency) and hypermethylating (SAM supplementation) alterations of the one-carbon metabolism. We found that DNA methylases (DNMT1, 3a and 3b) and a putative demethylase (MBD2) were differently modulated, in line with the previously observed changes of PSEN1 methylation pattern in the same experimental conditions.</description><dc:title>DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models - Corrected Proof</dc:title><dc:creator>Andrea Fuso, Vincenzina Nicolia, Rosaria A. Cavallaro, Sigfrido Scarpa</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-23</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-23</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000616/abstract?rss=yes"><title>Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000616/abstract?rss=yes</link><description>Abstract: It is now well accepted that oxysterols play important roles in the formation of atherosclerotic plaque, involving cytotoxic, pro-oxidant and proinflammatory processes. It has been recently suggested that tomato lycopene may act as a preventive agent in atherosclerosis, although the exact mechanism of such a protection is not clarified. The main aim of this study was to investigate whether lycopene is able to counteract oxysterol-induced proinflammatory cytokines cascade in human macrophages, limiting the formation of atherosclerotic plaque. Therefore, THP-1 macrophages were exposed to two different oxysterols, such as 7-keto-cholesterol (4-16 μM) and 25-hydroxycholesterol (2-4 μM), alone and in combination with lycopene (0.5–2 μM). Both oxysterols enhanced pro-inflammatory cytokine [interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor α) secretion and mRNA levels in a dose-dependent manner, although at different extent. These effects were associated with an increased reactive oxygen species (ROS) production through an enhanced expression of NAD(P)H oxidase. Moreover, a net increment of phosphorylation of extracellular regulated kinase 1/2, p-38 and Jun N-terminal kinase and of nuclear factor kB (NF-κB) nuclear binding was observed. Lycopene prevented oxysterol-induced increase in pro-inflammatory cytokine secretion and expression. Such an effect was accompanied by an inhibition of oxysterol-induced ROS production, mitogen-activated protein kinase phosphorylation and NF-κB activation. The inhibition of oxysterol-induced cytokine stimulation was also mimicked by the specific NF-κB inhibitor pyrrolidine dithiocarbamate. Moreover, the carotenoid increased peroxisome proliferator-activated receptor γ levels in THP-1 macrophages. Taken all together, these data bring new information on the anti-atherogenic properties of lycopene, and on its mechanisms of action in atherosclerosis prevention.</description><dc:title>Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression - Corrected Proof</dc:title><dc:creator>Paola Palozza, Rossella Simone, Assunta Catalano, Giovanni Monego, Angela Barini, Maria Cristina Mele, Nadia Parrone, Sonia Trombino, Nevio Picci, Franco O. Ranelletti</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-23</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-23</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528631000063X/abstract?rss=yes"><title>Anti-obesity effect of carboxymethyl schitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528631000063X/abstract?rss=yes</link><description>Abstract: The aim of this study was to investigate the anti-obesity effect of carboxymethyl-chitin (CM-chitin), a water-soluble derivative of chitin, by measuring lipid accumulation and adipogenesis related factors in 3T3-L1 adipocytes. CM-chitin was synthesized by means of carboxymethylation reaction. Its inhibitory effect on lipid accumulation was investigated by measuring triglyceride content and glycerol release level. The gene and protein levels associated with adipogenesis were determined using reverse transcriptase-polymerase chain reaction and Western blot analysis. Treatment with CM-chitin reduced triglyceride content and enhanced glycerol secretion in a dose-dependent manner. CM-chitin induced the down-regulation of adipogenesis related transcriptional factors and adipocyte specific gene promoters. Moreover, the specific mechanism by CM-chitin was confirmed by transcriptional activations of the phosphorylated adenosine monophosphate-activated protein kinase (AMPK) and aquaporin-7. These results suggest that CM-chitin exerts anti-adipogenic effect on lipid accumulation through modulations of AMPK and aquaporin-7 signal pathways.</description><dc:title>Anti-obesity effect of carboxymethyl schitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes - Corrected Proof</dc:title><dc:creator>Chang-Suk Kong, Jung-Ae Kim, Soon-Sun Bak, Hee-Guk Byun, Se-Kwon Kim</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-23</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-23</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000641/abstract?rss=yes"><title>Effects of glutamine administration on inflammatory responses in chronic ethanol-fed rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000641/abstract?rss=yes</link><description>Abstract: The purpose of this study was to investigate the effects of glutamine supplementation on inflammatory responses in chronic ethanol-fed rats. Male Wistar rats weighing about 160 g were divided into five groups. Two groups were fed a normal liquid diet and three groups were fed a glutamine-containing liquid diet. After 1 week, one of the normal liquid diet groups was fed an ethanol-containing liquid diet (CE), and the other group served as the control (CC) group. At the same time, one of the glutamine-containing liquid diet groups was continually fed the same diet (GCG), but the other two groups were fed ethanol-containing diet supplemented with glutamine (GEG) or without glutamine (GE). The following items were analyzed: (1) liver function, (2) cytokine contents, and (3) hepatic oxidative stress. The activities of aspartate transaminase (AST) and alanine transaminase (ALT) and levels of tumor necrosis factor (TNF)-α and interleukin (IL)-1β in the CE group had significantly increased. In addition, hepatic cytochrome P450 2E1 (CYP2E1) expression had significantly increased in the CE, GE and GEG groups. However, the activities of AST and ALT and levels of TNF-α and IL-1β in the GE group were significantly lower than those of the CE group. The results suggest that the plasma inflammatory responses of rats fed an ethanol-containing liquid diet for 7 weeks significantly increased. However, pretreatment with glutamine improved the plasma inflammatory responses induced by ethanol.</description><dc:title>Effects of glutamine administration on inflammatory responses in chronic ethanol-fed rats - Corrected Proof</dc:title><dc:creator>Hsiang-Chi Peng, Ya-Ling Chen, Jiun-Rong Chen, Sien-Sing Yang, Kuan-Hsun Huang, Yi-Chin Wu, Yun-Ho Lin, Suh-Ching Yang</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-23</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-23</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000495/abstract?rss=yes"><title>Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000495/abstract?rss=yes</link><description>Abstract: Although activation of the mammalian target of rapamycin complex/p70 S6 kinase (S6K1) pathway by leucine is efficient to stimulate muscle protein synthesis, it can also exert inhibition on the early steps of insulin signaling leading to insulin resistance. We investigated the impact of 5-week leucine supplementation on insulin signaling and sensitivity in 4-month old rats fed a 15% protein diet supplemented (LEU) or not (C) with 4.5% leucine. An oral glucose tolerance test was performed in each rat at the end of the supplementation and glucose transport was measured in vitro using isolated epitrochlearis muscles incubated with 2-deoxy-d-[3H]-glucose under increasing insulin concentrations. Insulin signaling was assessed on gastrocnemius at the postabsorptive state or 30 and 60 min after gavage with a nutrient bolus. Tyrosine phosphorylation of IRβ, IRS1 and PI3 kinase activity were reduced in LEU group 30 min after feeding (−36%, −36% and −38% respectively, P&lt;.05) whereas S6K1, S6rp and 4EBP1 phosphorylations were similar. Overall glucose tolerance was reduced in leucine-supplemented rats and was associated with accumulation of perirenal adipose tissue (+27%, P&lt;.05). Conversely, in vitro insulin-response of muscle glucose transport tended to be improved in leucine-supplemented rats. In conclusion, dietary leucine supplementation in adult rats induced a delay in the postprandial stimulation in the early steps of muscle insulin signaling without muscle resistance on insulin-induced glucose uptake. However, it resulted in overall glucose intolerance linked to increased local adiposity. Further investigations are necessary to clearly define the beneficial and/or deleterious effects of chronic dietary leucine supplementation in healthy subjects.</description><dc:title>Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance - Corrected Proof</dc:title><dc:creator>Michèle Balage, Joëlle Dupont, Isabelle Mothe-Satney, Sophie Tesseraud, Laurent Mosoni, Dominique Dardevet</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.02.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-17</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-17</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000513/abstract?rss=yes"><title>Combined arginine and ascorbic acid treatment induces apoptosis in the hepatoma cell line HA22T/VGH and changes in redox status involving the pentose phosphate pathway and reactive oxygen and nitrogen species - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000513/abstract?rss=yes</link><description>Abstract: Arginine is a physiological substrate for nitric oxide synthase to generate nitric oxide (NO), which can influence tumor cell survival, while ascorbic acid is selectively toxic for cancer cells. This study explored the effect of an arginine/ascorbic acid combination on human cancer cell lines. The hepatoma cell line HA22T/VGH was the most sensitive of the tested cells to combination treatment. A combination of 5.74 mM of arginine and 0.57 mM of ascorbic acid induced HA22T/VGH cell death through apoptosis and an increase in levels of reactive oxygen species and NO, as well as its stable products NO2− and NO3−. The combination also reduced the activity of glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and transaldolase in the pentose phosphate pathway, a major mechanism for producing NADPH, resulting in a marked decrease in intracellular NADPH levels. A dramatic decrease in intracellular glutathione (GSH) levels, a decrease in the mitochondrial membrane potential, ATP depletion and release of cytochrome c were also seen. Caspase-9 and caspase-3 were activated, apoptotic protein Bax expression increased and the expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL decreased. These results suggest that this combination induced HA22T/VGH cell death by interfering with redox state regulation by a reduction in pentose phosphate pathway activity and increasing oxidative and nitrosative stress.</description><dc:title>Combined arginine and ascorbic acid treatment induces apoptosis in the hepatoma cell line HA22T/VGH and changes in redox status involving the pentose phosphate pathway and reactive oxygen and nitrogen species - Corrected Proof</dc:title><dc:creator>Bau-Shan Hsieh, Li-Wen Huang, Shu-Jem Su, Hsiao-Ling Cheng, Yu-Chen Hu, Thu-Ching Hung, Kee-Lung Chang</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-17</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-17</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000379/abstract?rss=yes"><title>Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000379/abstract?rss=yes</link><description>Abstract: Previous studies reported that the age-related decline in testosterone biosynthesis is associated with a decrease in the steroidogenic acute regulatory (StAR) protein which regulates the rate-limiting step of testosterone biosynthesis. To explore the possibility of delaying this decline using a dietary approach, we have examined the effect of a natural flavonoid, apigenin, on StAR gene expression in mouse Leydig cells. Incubation of these cells with the flavonoid enhanced cyclic adenosine monophosphate (cAMP)-induced steroidogenesis and StAR protein expression. The results from the analyses of StAR mRNA by reverse transcription-polymerase chain reaction and the luciferase assays of StAR promoter activity indicated that this flavonoid enhanced StAR gene expression at the level of transcription. Further studies showed that apigenin blocked the thromboxane A2 receptor and interrupted the signaling through the cyclooxygenase-2-thromboxane A synthase-thromboxane A2-receptor pathway, resulting in a reduction of DAX-1 (dosage sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene-1) protein, a transcriptional repressor of StAR gene expression. When DAX-1 protein was reduced, the sensitivity of the Leydig cells was dramatically enhanced, with sub-threshold level of cAMP being able to induce maximal levels of StAR protein expression and steroid hormone production. The present study suggests a potential application of apigenin to improve StAR protein expression and steroidogenic sensitivity of aging Leydig cells.</description><dc:title>Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells - Corrected Proof</dc:title><dc:creator>Wei Li, Akhilesh K. Pandey, Xiangling Yin, Jau-Jiin Chen, Douglas M. Stocco, Paula Grammas, XingJia Wang</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-01</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-01</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000380/abstract?rss=yes"><title>Liver fatty acid-binding protein and obesity - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000380/abstract?rss=yes</link><description>Abstract: While low levels of unesterified long chain fatty acids (LCFAs) are normal metabolic intermediates of dietary and endogenous fat, LCFAs are also potent regulators of key receptors/enzymes and at high levels become toxic detergents within the cell. Elevated levels of LCFAs are associated with diabetes, obesity and metabolic syndrome. Consequently, mammals evolved fatty acid-binding proteins (FABPs) that bind/sequester these potentially toxic free fatty acids in the cytosol and present them for rapid removal in oxidative (mitochondria, peroxisomes) or storage (endoplasmic reticulum, lipid droplets) organelles. Mammals have a large (15-member) family of FABPs with multiple members occurring within a single cell type. The first described FABP, liver-FABP (L-FABP or FABP1), is expressed in very high levels (2–5% of cytosolic protein) in liver as well as in intestine and kidney. Since L-FABP facilitates uptake and metabolism of LCFAs in vitro and in cultured cells, it was expected that abnormal function or loss of L-FABP would reduce hepatic LCFA uptake/oxidation and thereby increase LCFAs available for oxidation in muscle and/or storage in adipose. This prediction was confirmed in vitro with isolated liver slices and cultured primary hepatocytes from L-FABP gene-ablated mice. Despite unaltered food consumption when fed a control diet ad libitum, the L-FABP null mice exhibited age- and sex-dependent weight gain and increased fat tissue mass. The obese phenotype was exacerbated in L-FABP null mice pair fed a high-fat diet. Taken together with other findings, these data suggest that L-FABP could have an important role in preventing age- or diet-induced obesity.</description><dc:title>Liver fatty acid-binding protein and obesity - Corrected Proof</dc:title><dc:creator>Barbara P. Atshaves, Gregory G. Martin, Heather A. Hostetler, Avery L. McIntosh, Ann B. Kier, Friedhelm Schroeder</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-06-01</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-06-01</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000306/abstract?rss=yes"><title>White adipose tissue genome wide-expression profiling and adipocyte metabolic functions after soy protein consumption in rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000306/abstract?rss=yes</link><description>Abstract: Obesity is associated with an increase in adipose tissue mass due to an imbalance between high dietary energy intake and low physical activity; however, the type of dietary protein may contribute to its development. The aim of the present work was to study the effect of soy protein versus casein on white adipose tissue genome profiling, and the metabolic functions of adipocytes in rats with diet-induced obesity. The results showed that rats fed a Soy Protein High-Fat (Soy HF) diet gained less weight and had lower serum leptin concentration than rats fed a Casein High-Fat (Cas HF) diet, despite similar energy intake. Histological studies indicated that rats fed the Soy HF diet had significantly smaller adipocytes than those fed the Cas HF diet, and this was associated with a lower triglyceride/DNA content. Fatty acid synthesis in isolated adipocytes was reduced by the amount of fat consumed but not by the type of protein ingested. Expression of genes of fatty acid oxidation increased in adipose tissue of rats fed Soy diets; microarray analysis revealed that Soy protein consumption modified the expression of 90 genes involved in metabolic functions and inflammatory response in adipose tissue. Network analysis showed that the expression of leptin was regulated by the type of dietary protein and it was identified as a central regulator of the expression of lipid metabolism genes in adipose tissue. Thus, soy maintains the size and metabolic functions of adipose tissue through biochemical adaptations, adipokine secretion, and global changes in gene expression.</description><dc:title>White adipose tissue genome wide-expression profiling and adipocyte metabolic functions after soy protein consumption in rats - Corrected Proof</dc:title><dc:creator>Maria E. Frigolet, Nimbe Torres, Laura Uribe-Figueroa, Claudia Rangel, Gerardo Jimenez-Sanchez, Armando R. Tovar</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-05-17</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-05-17</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000343/abstract?rss=yes"><title>Dietary catechins and procyanidins modulate zinc homeostasis in human HepG2 cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000343/abstract?rss=yes</link><description>Abstract: Catechins and their polymers procyanidins are health-promoting flavonoids found in edible vegetables and fruits. They act as antioxidants by scavenging reactive oxygen species and by chelating the redox-active metals iron and copper. They also behave as signaling molecules, modulating multiple cell signalling pathways and gene expression, including that of antioxidant enzymes. This study aimed at determining whether catechins and procyanidins interact with the redox-inactive metal zinc and at assessing their effect on cellular zinc homeostasis. We found that a grape-seed procyanidin extract (GSPE) and the green tea flavonoid (−)-epigallocatechin-3-gallate (EGCG) bind zinc cations in solution with higher affinity than the zinc-specific chelator Zinquin, and dose-dependently prevent zinc-induced toxicity in the human hepatocarcinoma cell line HepG2, evaluated by the lactate dehydrogenase test. GSPE and EGCG hinder intracellular accumulation of total zinc, measured by atomic flame absorption spectrometry, concomitantly increasing the level of cytoplasmic labile zinc detectable by Zinquin fluorescence. Concurrently, GSPE and EGCG inhibit the expression, evaluated at the mRNA level by quantitative reverse transcriptase-polymerase chain reaction, of zinc-binding metallothioneins and of plasma membrane zinc exporter ZnT1 (SLC30A1), while enhancing the expression of cellular zinc importers ZIP1 (SLC39A1) and ZIP4 (SLC39A4). GSPE and EGCG also produce all these effects when HepG2 cells are stimulated to import zinc by treatment with supplemental zinc or the proinflammatory cytokine interleukin-6. We suggest that extracellular complexation of zinc cations and the elevation of cytoplasmic labile zinc may be relevant mechanisms underlying the modulation of diverse cell signaling and metabolic pathways by catechins and procyanidins.</description><dc:title>Dietary catechins and procyanidins modulate zinc homeostasis in human HepG2 cells - Corrected Proof</dc:title><dc:creator>Isabel M. Quesada, Mario Bustos, Mayte Blay, Gerard Pujadas, Anna Ardèvol, M. Josepa Salvadó, Cinta Bladé, Lluís Arola, Juan Fernández-Larrea</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-05-17</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-05-17</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000744/abstract?rss=yes"><title>Promoter analysis of the human ascorbic acid transporters SVCT1 and 2: mechanisms of adaptive regulation in liver epithelial cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000744/abstract?rss=yes</link><description>Abstract: Ascorbic acid, the active form of vitamin C, is a vital antioxidant in the human liver, yet the molecular mechanisms involved in the regulation of ascorbic acid transporters [human sodium-dependent vitamin C transporters (hSVCT) 1 and 2] in liver cells are poorly understood. Therefore, we characterized the minimal promoter regions of hSVCT1 and 2 in cultured human liver epithelial cells (HepG2) and examined the effects of ascorbic acid deprivation and supplementation on activity and regulation of the transport systems. Identified minimal promoters required for basal activity were found to include multiple cis regulatory elements, whereas mutational analysis demonstrated that HNF-1 sites in the hSVCT1 promoter and KLF/Sp1 sites in the hSVCT2 promoter were essential for activities. When cultured in ascorbic acid deficient or supplemented media, HepG2 cells demonstrated significant (P&lt;.01) and specific reciprocal changes in [14C]-Ascorbic acid uptake, and in hSVCT1 mRNA and protein levels as well as hSVCT1 promoter activity. However, no significant changes in hSVCT2 expression or promoter activity were observed during ascorbic acid deficient or supplemented conditions. We mapped the ascorbic acid responsive region in the hSVCT1 promoter and determined that HNF-1 sites are important for the adaptive regulation response. The results of these studies further characterize the hSVCT1 and 2 promoters establish that ascorbic acid uptake by human liver epithelial cells is adaptively regulated and show that transcriptional mechanisms via HNF-1 in the hSVCT1 promoter may, in part, be involved in this regulation.</description><dc:title>Promoter analysis of the human ascorbic acid transporters SVCT1 and 2: mechanisms of adaptive regulation in liver epithelial cells - Corrected Proof</dc:title><dc:creator>Jack C. Reidling, Stanley A. Rubin</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.03.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-05-17</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-05-17</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000094/abstract?rss=yes"><title>An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-Ay mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000094/abstract?rss=yes</link><description>Abstract: An ethanolic extract of Artemisia dracunculus L. (PMI 5011) has been observed to decrease glucose and insulin levels in animal models, but the cellular mechanisms by which insulin action is enhanced in vivo are not precisely known. In this study, we evaluated the effects of PMI 5011 to modulate gene expression and cellular signaling through the insulin receptor in skeletal muscle of KK-Ay mice. Eighteen male KK-Ay mice were randomized to a diet (w/w) mixed with PMI 5011 (1%) or diet alone for 8 weeks. Food intake, adiposity, glucose and insulin were assessed over the study, and at study completion, vastus lateralis muscle was obtained to assess insulin signaling parameters and gene expression. Animals randomized to PMI 5011 were shown to have enhanced insulin sensitivity and increased insulin receptor signaling, i.e., IRS-associated PI-3 kinase activity, Akt-1 activity and Akt phosphorylation, in skeletal muscle when compared to control animals (P&lt;.01, P&lt;.01 and P&lt;.001, respectively). Gene expression for insulin signaling proteins, i.e., IRS-1, PI-3 kinase and Glut-4, was not increased, although a relative increase in protein abundance was noted with PMI 5011 treatment. Gene expression for specific ubiquitin proteins and specific 20S proteasome activity, in addition to skeletal muscle phosphatase activity, i.e., PTP1B activity, was significantly decreased in mice randomized to PMI 5011 relative to control. Thus, the data demonstrate that PMI 5011 increases insulin sensitivity and enhances insulin receptor signaling in an animal model of insulin resistance. PMI 5011 may modulate skeletal muscle protein degradation and phosphatase activity as a possible mode of action.</description><dc:title>An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-Ay mice - Corrected Proof</dc:title><dc:creator>Zhong Q. Wang, David Ribnicky, Xian H. Zhang, Aamir Zuberi, Ilya Raskin, Yongmei Yu, William T. Cefalu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.015</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-05-06</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-05-06</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000355/abstract?rss=yes"><title>Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000355/abstract?rss=yes</link><description>Abstract: The effects of vitamin C (VC) on osteoclastogenesis were studied in vivo using ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rats and in vitro using bone marrow-derived monocyte/macrophage cells (BMMs). The results confirmed previous findings of increases in the number of osteoclasts and in bone resorption at 2 and 3 weeks, but not 1 week, of VC-deficiency in ODS rats. The mRNA and protein levels of receptor activator nuclear factor kappaB (RANK) ligand and osteoprotegerin, and the mRNA level of macrophage-colony stimulating factor (M-CSF) in the proximal tibia of VC-deficient rats did not differ from those in VC-supplemented control rats. However, the mRNA levels of RANK, c-fos and c-jun were significantly increased at as early as 1 week of VC-deficiency. These results suggested that VC-deficiency stimulated osteoclastogenesis by increasing RANK expression. The osteoclastic differentiation of BMMs was suppressed in the presence of VC. The suppressed osteoclastogenesis was associated with decreased levels of RANK, c-fos and c-jun. The pretreatment of BMMs with VC or PD 98059, a specific inhibitor of extracellular signal regulated kinase (ERK)-activating MEK1, decreased the expression of RANK induced by M-CSF. VC inhibited the M-CSF-induced activation of ERK. These results suggested that VC-deficiency increased osteoclastogenesis by increasing RANK expression mediated through the activation of ERK.</description><dc:title>Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression - Corrected Proof</dc:title><dc:creator>Mamiko Hie, Ikuyo Tsukamoto</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-05-05</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-05-05</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000318/abstract?rss=yes"><title>Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000318/abstract?rss=yes</link><description>Abstract: Chemopreventive activities of the dietary isoprenoids β-ionone (βI) and geraniol (GOH) were evaluated during the promotion phase of hepatocarcinogenesis. Over 5 consecutive weeks, rats received daily 16 mg/100 g body weight (b.w.) of βI (βI group), 25 mg/100 g b.w. of GOH (GOH group), or only corn oil (CO group, controls). Compared to the CO group, the following was observed: only the βI group showed a decrease in the mean number of visible hepatocyte nodules (P&lt;.05); βI and GOH groups had reduced mean number of persistent preneoplastic lesions (pPNLs) (P&lt;.05), but no differences regarding number of remodeling PNL (rPNLs) were observed; only the βI group exhibited smaller rPNL size and percentage of liver sections occupied by pPNLs (P&lt;.05), whereas the GOH group displayed a smaller percentage of liver sections occupied by rPNLs (P&lt;.05); a trend was observed in the βI group, which showed reduced cell proliferation of pPNLs (P&lt;.10), and the GOH group had increased apoptosis in pPNLs and rPNLs (P&lt;.05); only the βI group displayed reduced total plasma cholesterol concentrations (P&lt;.05) and increased hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase mRNA levels (P&lt;.05); only the GOH group had lower hepatic membrane RhoA protein levels (P&lt;.05); both the βI- and GOH-treated groups had higher hepatic concentrations of βI and GOH, respectively (P&lt;.05). Given these data, βI and GOH show promising chemopreventive effects during promotion of hepatocarcinogenesis by acting through distinct mechanism of actions: βI may inhibit cell proliferation and modulate HMGCoA reductase, and GOH can induce apoptosis and inhibit RhoA activation.</description><dc:title>Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA - Corrected Proof</dc:title><dc:creator>Mônica Testoni Cardozo, Aline de Conti, Thomas Prates Ong, Clarissa Scolastici, Eduardo Purgatto, Maria Aderuza Horst, Bruna Kempfer Bassoli, Fernando Salvador Moreno</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-05-03</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-05-03</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000331/abstract?rss=yes"><title>Hyperinsulinemia and ectopic fat deposition can develop in the face of hyperadiponectinemia in young obese rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000331/abstract?rss=yes</link><description>Abstract: Serum adiponectin has been reported to inversely correlate with the degree of adiposity in children. However, the relative contribution of adiponectin-dependent signaling to the development of metabolic syndrome in childhood obesity is unclear. We overfed prepubertal, male Sprague–Dawley rats a high-fat diet via total enteral nutrition. Excessive caloric intake led to obesity, increased body weight and fat mass; dyslipidemia; ectopic fat deposition; and hyperinsulinemia (P&lt;.05). Expression of fatty acid transporter FAT/CD36 was elevated in both liver and skeletal muscle (P&lt;.05). Hepatic Akt phosphorylation was elevated (P&lt;.05) and FoxO1 protein in hepatic nuclear extracts was reduced (P&lt;.05) in the face of hyperinsulinemia, whereas no increase in Akt phosphorylation or decrease in nuclear FoxO1 was observed in skeletal muscle. Overfeeding increased serum adiponectin concentration from 24.6±1.9 μg/ml to 46.3±5.9 μg/ml (P&lt;.004), and positively correlated with increased adipose tissue mass. The expression of the inflammatory cytokine tumor necrosis factor α in the adipose tissue was unchanged. Adiponectin-mediated adenosine monophosphate (AMP) kinase phosphorylation, peroxisome proliferator-activator receptor-α expression and the expression of genes involved in fatty acid oxidation were elevated in both liver and muscle (P&lt;.05). These data (1) demonstrate that excessive intake of a high-fat diet in young rats results in “adiponectin-independent” increases in ectopic fat deposition and hyperinsulinemia, (2) suggest that fatty acid transport is a major mechanism underlying ectopic fat deposition, (3) demonstrate tissue-specific differences in the response of Akt-FoxO signaling to hyperinsulinemia following the development of pediatric obesity and (4) suggest age-related differences in the role of adiponectin in pathological responses associated with obesity.</description><dc:title>Hyperinsulinemia and ectopic fat deposition can develop in the face of hyperadiponectinemia in young obese rats - Corrected Proof</dc:title><dc:creator>John C. Marecki, Martin J.J. Ronis, Kartik Shankar, Thomas M. Badger</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-05-03</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-05-03</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528631000029X/abstract?rss=yes"><title>Involvement of omega-3 fatty acids in emotional responses and hyperactive symptoms - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528631000029X/abstract?rss=yes</link><description>Abstract: Biochemical evidence suggests a role for n-3 polyunsaturated fatty acids (n-3 PUFAs) in the regulation of behavioral disturbances. A number of studies have revealed an association between reduced n-3 PUFA levels and attention-deficit hyperactivity disorder or depression. Here, we summarize the main findings regarding the association between n-3 PUFA and hyperactive and emotional disorders, and discuss potential mechanisms of action. Because the basal ganglia are involved in the control of locomotion and emotion, we examined published data regarding the role of n-3 PUFA in dopamine (DA) regulation in the basal ganglia. These results are discussed in the light of recent data from our laboratory suggesting an association between the drop in melatonin in the pineal gland and the increase in DA in the striatum and nucleus accumbens of n-3 PUFA-deprived rodents.</description><dc:title>Involvement of omega-3 fatty acids in emotional responses and hyperactive symptoms - Corrected Proof</dc:title><dc:creator>Monique Lavialle, Isabelle Denis, Philippe Guesnet, Sylvie Vancassel</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-30</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-30</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528631000032X/abstract?rss=yes"><title>Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528631000032X/abstract?rss=yes</link><description>Abstract: We have previously shown that toll-like receptor-4 (Tlr4) is involved in obesity-induced inflammation in adipose tissue (AT). However, less is known about the role of Tlr2 in this process. To determine the involvement of this receptor in obesity-induced inflammation, we utilized male Tlr2−/− mice that were backcrossed onto a mouse model of diet-induced obesity (DIO). Mice were fed either low-fat control (LFD) or high-fat diet (HFD) ad libitum for 16 weeks. Despite negligible differences in body weight or energy intake, Tlr2−/− mice were protected from HFD-induced adiposity as was evident by reduced epididymal fat pad weight and carcass lipid content. Corresponding with these effects was a blunted accumulation of F4/80-positive macrophages in AT of Tlr2−/− mice. Furthermore, transcript abundance of proinflammatory mediators, including monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNFα) and nitric oxide synthase-2 (NOS2) in AT of Tlr2−/− mice, was lower or less responsive to DIO. There were no significant differences in serum markers of insulin sensitivity (data not shown). However, adipocytes derived from stromal vascular cells (SVCs) isolated from AT of Tlr2−/− mice had considerably greater basal and insulin-stimulated glucose uptake as compared with those obtained from Tlr2+/+ mice. Furthermore, the absence of Tlr2−/− precluded the induction of insulin resistance by zymosan A (ZymA) but not by palmitate. These data indicate that Tlr2 may be directly involved in HFD-induced inflammation and may also regulate basal and insulin-stimulated glucose uptake in adipocytes.</description><dc:title>Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes - Corrected Proof</dc:title><dc:creator>Jeremy E. Davis, Douglas R. Braucher, Jennifer Walker-Daniels, Michael E. Spurlock</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-30</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-30</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000100/abstract?rss=yes"><title>Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000100/abstract?rss=yes</link><description>Abstract: A balance between zinc uptake by ZIP (SLC39) and efflux of zinc from the cytoplasm into subcellular organelles and out of the cell by ZnT (SLC30) transporters is crucial for zinc homeostasis. It is not clear whether normal and cancerous pancreatic cells respond differently to increased extracellular zinc concentrations. Use of flow cytometry-based methods revealed that treatment with as little as 0.01 mM zinc induced significant cytotoxicity in two human ductal adenocarcinoma cell lines. In contrast, normal human pancreatic islet cells tolerated as high as 0.5 mM zinc. Insulinoma cell lines of mouse and rat origin also succumbed to high concentrations of zinc. Exposure to elevated zinc concentrations enhanced the numbers of carcinoma but not primary islet cells staining with the cell-permeable zinc-specific fluorescent dye, FluoZin-3, indicating increased zinc influx in transformed cells. Mitochondrial membrane depolarization, superoxide generation, decreased antioxidant thiols, intracellular acidosis and activation of intracellular caspases characterized zinc-induced carcinoma cell death. Only the antioxidant glutathione but not inhibitors of enzymes implicated in apoptosis or necrosis prevented zinc-induced cytotoxicity in insulinoma cells. Immunoblotting revealed that zinc treatment increased the ubiquitination of proteins in cancer cells. Importantly, zinc treatment up-regulated the expression of ZnT-1 gene in a rat insulinoma cell line and in two human ductal adenocarcinoma cell lines. These results indicate that the exposure of pancreatic cancer cells to elevated extracellular zinc concentrations can lead to cytotoxic cell death characterized by increased protein ubiquitination and up-regulation of the zinc transporter ZnT-1 gene expression.</description><dc:title>Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells - Corrected Proof</dc:title><dc:creator>Arathi K. Jayaraman, Sundararajan Jayaraman</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-14</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-14</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000124/abstract?rss=yes"><title>Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000124/abstract?rss=yes</link><description>Abstract: Allergic airways disease (AAD) is associated with an increased influx of eosinophils to the lungs, mucus hypersecretion and Th2 cytokine production. Dietary antioxidant supplementation may alter cytokine responses and thus allergic inflammation. Lycopene is a potent dietary antioxidant. The objective of this study was to investigate the effects of lycopene, on allergic inflammation, in a mouse model of AAD. BALB/c mice receiving lycopene supplement or control were intraperitoneally sensitised and intranasally challenged with ovalbumin (OVA) to induce AAD. The effect of supplementation on inflammatory cell influx into bronchoalveolar lavage fluid, lung tissue and blood, mucus-secreting cell numbers in the airways, draining lymph node OVA-specific cytokine release, serum IgG1 levels and lung function in AAD was assessed. Supplementation reduced eosinophilic infiltrates in the bronchoalveolar lavage fluid, lung tissue and blood, and mucus-secreting cell numbers in the airways. The OVA-specific release of Th2-associated cytokines IL-4 and IL-5 was also reduced. We conclude that supplementation with lycopene reduces allergic inflammation both in the lungs and systemically, by decreasing Th2 cytokine responses. Thus, lycopene supplementation may have a protective effect against asthma.</description><dc:title>Dietary lycopene supplementation suppresses Th2 responses and lung eosinophilia in a mouse model of allergic asthma - Corrected Proof</dc:title><dc:creator>Leia C. Hazlewood, Lisa G. Wood, Philip M. Hansbro, Paul S. Foster</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-14</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-14</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000082/abstract?rss=yes"><title>Maternal dietary loads of α-tocopherol depress protein kinase C signaling and synaptic plasticity in rat postnatal developing hippocampus and promote permanent deficits in adult offspring - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000082/abstract?rss=yes</link><description>Abstract: Vitamin E (α-tocopherol) supplementation has been tested as prophylaxis against gestational disorders associated with oxidative damage. However, recent evidence showing that high maternal α-tocopherol intake can adversely affect offspring development raises concerns on the safety of vitamin E extradosages during pregnancy. Besides acting as an antioxidant, α-tocopherol depresses cell proliferation and modulates cell signaling through inhibiting protein kinase C (PKC), a kinase that is deeply involved in neural maturation and plasticity. Possible effects of α-tocopherol loads in the maturing brain, where PKC dysregulation is associated to developmental dysfunctions, are poorly known. Here, supranutritional doses of α-tocopherol were fed to pregnant and lactating dams to evaluate the effects on PKC signaling and morphofunctional maturation in offspring hippocampus. Results showed that maternal supplementation potentiates hippocampal α-tocopherol incorporation in offspring and leads to marked decrease of PKC phosphorylation throughout postnatal maturation, accompanied by reduced phosphorylation of growth-associated protein-43 and myristoylated alanine-rich C kinase substrate, two PKC substrates involved in neural development and plasticity. Although processes of neuronal maturation, synapse formation and targeting appeared unaffected, offspring of supplemented mothers displayed a marked reduction of long-term synaptic plasticity in juvenile hippocampus. Interestingly, this impairment persisted in adulthood, when a deficit in hippocampus-dependent, long-lasting spatial memory was also revealed. In conclusion, maternal supplementation with elevated doses of α-tocopherol can influence cell signaling and synaptic plasticity in developing hippocampus and promotes permanent adverse effects in adult offspring. The present results emphasize the need to evaluate the safety of supranutritional maternal intake of α-tocopherol in humans.</description><dc:title>Maternal dietary loads of α-tocopherol depress protein kinase C signaling and synaptic plasticity in rat postnatal developing hippocampus and promote permanent deficits in adult offspring - Corrected Proof</dc:title><dc:creator>Michele Betti, Patrizia Ambrogini, Andrea Minelli, Alessandro Floridi, Davide Lattanzi, Stefano Ciuffoli, Corrado Bucherelli, Emilia Prospero, Andrea Frontini, Lory Santarelli, Elisabetta Baldi, Fernando Benetti, Francesco Galli, Riccardo Cuppini</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.014</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-12</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-12</prism:publicationDate><prism:section>ORIGINAL RESEARCH</prism:section></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000112/abstract?rss=yes"><title>Grape powder extract attenuates tumor necrosis factor α-mediated inflammation and insulin resistance in primary cultures of human adipocytes - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000112/abstract?rss=yes</link><description>Abstract: Grapes are rich in phenolic phytochemicals that possess anti-oxidant and anti-inflammatory properties. However, the ability of grape powder extract (GPE) to prevent inflammation and insulin resistance in human adipocytes caused by tumor necrosis factor α (TNFα), a cytokine elevated in plasma and white adipose tissue (WAT) of obese, diabetic individuals, is unknown. Therefore, we examined the effects of GPE on markers of inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes treated with TNFα. We found that GPE attenuated TNFα-induced expression of inflammatory genes including interleukin (IL)-6, IL-1β, IL-8, monocyte chemoattractant protein (MCP)-1, cyclooxygenase (COX)-2 and Toll-like receptor (TLR)-2. GPE attenuated TNFα-mediated activation of extracellular signal-related kinase (ERK) and c-Jun NH2-terminal kinase (JNK) and activator protein-1 (AP-1, i.e., c-Jun). GPE also attenuated TNFα-mediated IκBα degradation and nuclear factor-kappa B (NF-κB) activity. Finally, GPE prevented TNFα-induced expression of protein tyrosine phosphatase (PTP)-1B and phosphorylation of serine residue 307 of insulin receptor substrate-1 (IRS-1), which are negative regulators of insulin sensitivity, and suppression of insulin-stimulated glucose uptake. Taken together, these data demonstrate that GPE attenuates TNFα-mediated inflammation and insulin resistance in human adipocytes, possibly by suppressing the activation of ERK, JNK, c-Jun and NF-κB.</description><dc:title>Grape powder extract attenuates tumor necrosis factor α-mediated inflammation and insulin resistance in primary cultures of human adipocytes - Corrected Proof</dc:title><dc:creator>Chia-Chi Chuang, Akkarach Bumrungpert, Arion Kennedy, Angel Overman, Tiffany West, Brent Dawson, Michael K. McIntosh</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-12</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-12</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000136/abstract?rss=yes"><title>Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000136/abstract?rss=yes</link><description>Abstract: Typical omega 3 polyunsaturated fatty acids (n-3 PUFAs) are docosahexaenoic acid and eicosapentaenoic acid in the form of fish oils and α linolenic acid from flaxseed oil. Epidemiological studies suggested the benefits of n-3 PUFA on cardiovascular health. Intervention studies confirmed that the consumption of n-3 PUFA provided benefits for primary and secondary prevention of cardiovascular disease. Evidence from cellular and molecular research studies indicates that the cardioprotective effects of n-3 PUFA result from a synergism between multiple, intricate mechanisms that involve antiinflammation, proresolving lipid mediators, modulation of cardiac ion channels, reduction of triglycerides, influence on membrane microdomains and downstream cell signaling pathways and antithrombotic and antiarrhythmic effects. n-3 PUFAs inhibit inflammatory signaling pathways (nuclear factor-κ B activity) and down-regulate fatty acid (FA) synthesis gene expression (sterol regulatory element binding protein-1c) and up-regulate gene expression involved in FA oxidation (peroxisome proliferator-activated receptor α). This review examines the various mechanisms by which n-3 PUFA exert beneficial effects against CVD.</description><dc:title>Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids - Corrected Proof</dc:title><dc:creator>Yuriko Adkins, Darshan S. Kelley</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.12.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-12</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-12</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000367/abstract?rss=yes"><title>Role of zinc in cellular zinc trafficking and mineralization in a murine osteoblast-like cell line - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000367/abstract?rss=yes</link><description>Abstract: Zinc (Zn) supplementation stimulates bone growth in Zn-deficient humans and animals. A biphasic pattern of mineralization has been observed in cultured osteoblasts; an initiation phase and a progression phase. We used MC3T3-E1, a murine osteoblastic cell line, to elucidate the physiological role of Zn in osteoblast mineralization and cellular Zn trafficking during the mineralization event. Cells were cultured in media containing Chelex-treated fetal bovine serum and 1, 4, 10 and 20 μM Zn as ZnSO4 for 14 days (early phase of mineralization) or 21 days (mid-to-late phase of mineralization). During the early phase of mineralization, Alizarin Red staining indicated that mineralization was increased by Zn in a dose-dependent manner. Although Zn exposure did not affect monolayer Zn concentration, metallothionein (MT) mRNA expression increased dose-dependently as assessed by real-time PCR. During the late phase of mineralization, mineralization was maximal at 1 μM Zn and monolayer Zn concentration reflected Zn exposure. The increase in MT mRNA expression during the late phase was similar to that during the early phase, but the difference in expression between culture Zn concentrations tended to be smaller. ZnT-2 mRNA expression decreased significantly with increasing zinc concentrations in the culture medium during the early phase, but increased significantly during the late phase. Osteocalcin mRNA levels were positively correlated to Zn exposure at both time points. Taken together, we propose that Zn may play an important role in osteoblast mineralization through Zn trafficking involving Zn storage proteins and Zn transporters.</description><dc:title>Role of zinc in cellular zinc trafficking and mineralization in a murine osteoblast-like cell line - Corrected Proof</dc:title><dc:creator>Masashi Nagata, Bo Lönnerdal</dc:creator><dc:identifier>10.1016/j.jnutbio.2010.01.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-04-09</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-04-09</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002514/abstract?rss=yes"><title>A water-soluble extract of Petalonia binghamiae inhibits the expression of adipogenic regulators in 3T3-L1 preadipocytes and reduces adiposity and weight gain in rats fed a high-fat diet - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002514/abstract?rss=yes</link><description>Abstract: We previously showed that an ethanolic extract of the edible brown algae Petalonia binghamiae promotes the differentiation of 3T3-L1 preadipocytes and decreases hyperglycemia in streptozotocin-induced diabetic mice. Here, we report that a water-soluble extract of P. binghamiae thalli, prepared by enzymatic digestion, inhibits preadipocyte differentiation and adipogenesis in a dose-dependent manner. In differentiating 3T3-L1 preadipocytes, the extract (designated PBEE) decreased the expression of peroxisome proliferator-activated receptor γ, CCAAT/enhancer-binding proteins α and β, and fatty acid-binding protein aP2. It also inhibited the mitotic clonal expansion process of adipocyte differentiation, and it inhibited insulin-stimulated uptake of glucose into mature 3T3-L1 adipocytes by reducing phosphorylation of insulin receptor substrate-1. In rats with high-fat diet (HFD)-induced obesity, PBEE exhibited potent anti-obesity effects. In this animal model, increases in body weight and fat storage were suppressed by the addition of PBEE to the drinking water at 500 mg/L for 30 days. PBEE supplementation reduced serum levels of glutamic pyruvic and glutamic oxaloacetic transaminases and increased the serum level of high-density lipoprotein cholesterol. Moreover, it significantly decreased the accumulation of lipid droplets in liver tissue, suggesting a protective effect against HFD-induced hepatic steatosis. Taken together, these data demonstrate that PBEE inhibits preadipocyte differentiation and adipogenesis in cultured cells and in rodent models of obesity.</description><dc:title>A water-soluble extract of Petalonia binghamiae inhibits the expression of adipogenic regulators in 3T3-L1 preadipocytes and reduces adiposity and weight gain in rats fed a high-fat diet - Corrected Proof</dc:title><dc:creator>Seong-Il Kang, Moo-Han Kim, Hye-Sun Shin, Hyo-Min Kim, Youn-Suk Hong, Ji-Gweon Park, Hee-Chul Ko, Nam-Ho Lee, Wan-Seok Chung, Se-Jae Kim</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-03-24</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-03-24</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000021/abstract?rss=yes"><title>Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000021/abstract?rss=yes</link><description>Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the US and refers to a wide spectrum of liver damage, including simple steatosis, steatohepatitis, fibrosis and cirrhosis. The goal of the present study was to achieve a more detailed understanding of the molecular changes in response to high fat-induced liver steatosis through the identification of a differentially expressed liver transcriptome and proteome. Male C57/BL6 mice fed a high-fat lard diet for 8 weeks developed visceral obesity and hepatic steatosis characterized by significantly increased liver and plasma free fatty acid and triglyceride levels and plasma alanine aminotransferase activities. Transcriptome analysis demonstrated that, compared to the control diet (CD), high-fat diet changed the expression of 309 genes (132 up- and 177 down-regulated; by a twofold change and more, P&lt;.05). Multiple genes encoding proteins involved in lipogenesis were down-regulated, whereas genes involved in fatty acid oxidation were up-regulated. Proteomic analysis revealed 12 proteins which were differentially expressed. Of these, glutathione S-transferases mu1 and pi1 and selenium-binding protein 2 were decreased at both the gene and protein levels. This is the first study to perform a parallel transcriptomic and proteomic analysis of diet-induced hepatic steatosis. Several key pathways involving xenobiotic and lipid metabolism, the inflammatory response and cell-cycle control were identified. These pathways provide targets for future mechanistic and therapeutic studies as related to the development and prevention of NAFLD.</description><dc:title>Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease - Corrected Proof</dc:title><dc:creator>Irina A. Kirpich, Leila N. Gobejishvili, Marjorie Bon Homme, Sabine Waigel, Matt Cave, Gavin Arteel, Shirish S. Barve, Craig J. McClain, Ion V. Deaciuc</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-03-22</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-03-22</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000033/abstract?rss=yes"><title>Involvement of nucleophosmin/B23 in the cellular response to curcumin - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000033/abstract?rss=yes</link><description>Abstract: Nucleophosmin (NPM/B23) is a nucleolar phosphoprotein involved in cellular response to many different stimuli. Herein, we studied the molecular mechanism of NPM/B23 induction by curcumin, a natural AP-1 inhibitor with antitumor properties. Exposure to 5–30 μM curcumin significantly and dose-dependently increased the level of NPM/B23 in non-transformed NIH 3T3 cells but not HeLa cells and F9 cells. Besides, the transformed F9 and HeLa cells are more sensitive to curcumin-induced cell death and growth inhibition than NIH 3T3 cells. Overexpression of c-Jun, but not c-Fos, decreased ∼40% of NPM/B23 and enhanced the sensitivity of NIH 3T3 cells to 30 μM curcumin. Furthermore, down-regulation of NPM/B23 by transfection with NPM/B23 antisense plasmid enhanced the sensitivity to curcumin-induced cell death and growth inhibition. These results indicated that NPM/B23 expression regulates cellular sensitivity to curcumin. Besides, NPM/B23 knockdown may facilitate as a novel strategy to promote the sensitivity of cancer cells to curcumin.</description><dc:title>Involvement of nucleophosmin/B23 in the cellular response to curcumin - Corrected Proof</dc:title><dc:creator>Chien-Hui Weng, Benjamin Yat-Ming Yung, Jing-Jei Weng, Ming-Hsiu Wu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-03-22</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-03-22</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000045/abstract?rss=yes"><title>Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000045/abstract?rss=yes</link><description>Abstract: Low-grade inflammation is a risk factor for the onset of atherosclerosis. Little is known about the involvement of endotoxin absorption from the gut during the digestion of lipids. In the present study, we first investigated in humans the impact of a mixed meal containing dispersed lipids on postprandial endotoxemia and inflammation. We then investigated the effect of (i) oil emulsification in vivo in rats and (ii) fatty acid amounts in vitro using Caco-2 cells on postprandial endotoxemia. In humans, postprandial endotoxemia increased early after the meal. Moreover, we evidenced that the endotoxin receptor sCD14 increased during digestion and that chylomicrons could contribute to absorbed endotoxin transport. This could explain the significant peak of inflammatory cytokine IL-6 that we observed 2 h after the mixed meal. Interestingly, in rats, the emulsion led to both higher endotoxemia and hypertriglyceridemia than oil and compared to a control saline load. In vitro, incubation of Caco-2 cells with increasing fatty acid concentrations enhanced epithelial absorption of endotoxin. To our knowledge, this is the first study evidencing in healthy humans that, following a mixed meal containing lipids, increased endotoxemia is associated with raised sCD14 and a peak of IL-6. On a repeated basis, this may thus be a triggering cascade for the onset of atherosclerosis. In this respect, optimizing both dietary fat amount and structure could be a possible strategy to limit such low-grade endotoxemia and inflammation by the control of postprandial lipemia.</description><dc:title>Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation - Corrected Proof</dc:title><dc:creator>Fabienne Laugerette, Cécile Vors, Alain Géloën, Marie-Agnès Chauvin, Christophe Soulage, Stéphanie Lambert-Porcheron, Noël Peretti, Maud Alligier, Rémy Burcelin, Martine Laville, Hubert Vidal, Marie-Caroline Michalski</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-03-22</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-03-22</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286310000070/abstract?rss=yes"><title>Postnatal early overfeeding induces hypothalamic higher SOCS3 expression and lower STAT3 activity in adult rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286310000070/abstract?rss=yes</link><description>Abstract: Postnatal early overnutrition (EO) is a risk factor for future obesity and metabolic disorders. Rats raised in small litters (SLs) develop overweight, hyperphagia, hyperleptinemia, hyperinsulinemia and hypertension when adults. As obesity is related to hyperleptinemia, leptin resistance and metabolic syndrome, we aimed to investigate body composition, plasma hormone levels, glucose tolerance and the leptin signaling pathway in hypothalamus from early overfed animals at weaning and adulthood. To induce postnatal EO, we reduced litter size to three pups/litter (SL), and the groups with normal litter size (10 pups/litter) were used as control. Rats had free access to standard diet and water postweaning. Body weight and food intake were monitored daily, and offspring were killed at 21 (weaning) and 180 days old (adulthood). Postnatal EO group had higher body weight and total and visceral fat mass at both periods. Lean mass and serum high-density lipoprotein cholesterol (HDL-C) were higher at 21 days and lower at 180 days. Small litter rats presented higher levels of globulins at both periods, while albumin levels were higher at weaning and lower at adulthood. There was higher leptin, insulin and glucose serum concentrations at 21 days old, while no glucose intolerance was observed in adulthood. Leptin signaling pathway was unaffected at weaning. However, postnatal EO induced lower JAK2 and p-STAT3, and higher SOCS3 expression in adult animals, indicating central leptin resistance in adulthood. In conclusion, postnatal EO induces obesity, higher total and visceral fat mass, lower HDL-C and central leptin resistance in adult life.</description><dc:title>Postnatal early overfeeding induces hypothalamic higher SOCS3 expression and lower STAT3 activity in adult rats - Corrected Proof</dc:title><dc:creator>Ananda Lages Rodrigues, Egberto Gaspar de Moura, Magna Cottini Fonseca Passos, Isis Hara Trevenzoli, Ellen Paula Santos da Conceição, Isabela Teixeira Bonono, José Firmino Nogueira Neto, Patricia Cristina Lisboa</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.013</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-03-22</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-03-22</prism:publicationDate></item></rdf:RDF>